In conclusion, our studies establish a role of miR-137, a microRNA having potential tumor suppressor activity, in negatively regulating the expression of ERRα, a nuclear receptor considered to facilitate the progression of breast cancer, and in inhibiting the proliferative and migratory phenotype of some breast cancer cells. The gene discussed is ESRRA; the disease is neoplasm.